ksqtx.comHealthcareFounded: 2015Funding to Date: $257.46MM
KSQ Therapeutics is the developer of a genome-scale precision functional genomics platform, called CRISPRomics, designed to pinpoint therapeutic nodes that directly correlate genomic function to disease with unprecedented certainty and speed.
View Enterprise Value for KSQ Therapeutics.